Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/7787
Title: | Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level | Authors: | VENKEN, Koen HELLINGS, Niels THEWISSEN, Marielle SOMERS, Veerle HENSEN, Karen RUMMENS, Jean-Luc MEDAER, Rob Hupperts, Raymond STINISSEN, Piet |
Issue Date: | 2008 | Publisher: | BLACKWELL PUBLISHING | Source: | IMMUNOLOGY, 123(1). p. 79-89 | Abstract: | CD4(+) CD25(high) regulatory T cells (Tregs) of patients with relapsing-remitting (RR) multiple sclerosis (MS), in contrast to those of patients with secondary progressive (SP) MS, show a reduced suppressive function. In this study, we analysed forkhead box P3 (FOXP3) at the single-cell level in MS patients and controls (healthy individuals and patients with other neurological diseases) by means of intracellular flow cytometry. Our data revealed a reduced number of peripheral blood CD4(+) CD25(high) FOXP3(+) T cells and lower FOXP3 protein expression per cell in RR-MS patients than in SP-MS patients and control individuals, which was correlated with the suppressive capacity of Tregs in these patients. Interestingly, interferon (IFN)-beta-treated RR-MS patients showed restored numbers of FOXP3(+) Tregs. Furthermore, a higher percentage of CD4(+) CD25(high) FOXP3(+) Tregs in RR-MS patients, as compared with controls and SP-MS patients, expressed CD103 and CD49d, adhesion molecules involved in T-cell recruitment towards inflamed tissues. This was consistent with a significantly increased number of CD27(+) CD25(high) CD4(+) T cells in the cerebrospinal fluid (CSF), as compared with peripheral blood, in RR-MS patients. Taken together, these data show aberrant FOXP3 expression at the single-cell level correlated with Treg dysfunction in RR-MS patients. Our results also suggest that Tregs accumulate in the CSF of RR-MS patients, in an attempt to down-regulate local inflammation in the central nervous system. | Notes: | Hasselt Univ, Biomed Onderzoeksinst, B-3590 Diepenbeek, Belgium. Transnatl Univ Limburg, Sch Life Sci, Diepenbeek, Belgium. Virga Jesse Hosp, Clin Lab Expt Hematol, Hasselt, Belgium. Univ Hosp Maastricht, Dept Neurol, Maastricht, Netherlands.Stinissen, P, Hasselt Univ, Biomed Onderzoeksinst, Agoralaan Bldg A, B-3590 Diepenbeek, Belgium.piet.stinissen@uhasselt.be | Keywords: | autoimmunity; multiple sclerosis; tolerance; regulatory T cells; FOXP3 | Document URI: | http://hdl.handle.net/1942/7787 | ISSN: | 0019-2805 | e-ISSN: | 1365-2567 | DOI: | 10.1111/j.1365-2567.2007.02690.x | ISI #: | 000251586500014 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2009 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
232
checked on Sep 7, 2020
WEB OF SCIENCETM
Citations
284
checked on Sep 29, 2024
Page view(s)
74
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.